About: Utility of ranolazine in chronic stable angina patients.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Utility of ranolazine in chronic stable angina patients. Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on January 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2008 (ast) наукова стаття, опублікована в січні 2008 (uk) scientific article published on January 2008 (en) مقالة علمية نشرت في يناير 2008 (ar)
publication date	wds:Q37004023-AFF88E8F-3A53-43D2-8A68-B2629CEB45CC
publication date	2008-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37004023-BDFD3A20-B23F-4F95-9295-93A96D810AC9
language of work or name	English
cites work	wds:Q37004023-142E8DA2-BFAB-43B1-B9D0-C0C9D239DB26 wds:Q37004023-172BA0FC-C76C-4A60-8FFE-1B3739DD9860 wds:Q37004023-1E5C75BA-6811-42D3-AE44-48A1174B2EF8 wds:Q37004023-1F8A1C93-7A7C-4057-91D1-E7064F28322B wds:Q37004023-32ACC605-D27B-4ADE-B2C7-0CD7F955D870 wds:Q37004023-3449B332-1F39-4A07-B2D3-05DFF460CFB1 wds:Q37004023-37331013-4998-4FC1-8516-AFDF360D329F wds:Q37004023-3851A066-493B-4882-A78B-18FBF897E89B wds:Q37004023-562838FA-DA7B-486E-B67A-4909E7376DAF wds:Q37004023-568BDFBD-28E2-4FDE-98BE-D9A37319F8F7 wds:Q37004023-59B72B86-5A35-4E79-A09B-32C9AB2F1E95 wds:Q37004023-5B80E8E5-DAD9-4E98-9607-E3A8C9A70AF5 wds:Q37004023-65EF6038-B659-4395-9D3D-885F13FEEC1A wds:Q37004023-755546B0-3665-49D4-BAFB-225928CDF3E2 wds:Q37004023-791578A7-8070-49B1-8598-B2DD0DA78CD9 wds:Q37004023-873FE851-9679-4038-AE11-9AD49296DA76 wds:Q37004023-893C22D7-BCF0-4482-B0A5-2A52121DD68E wds:Q37004023-89C59F70-F157-4E85-95A9-6920BE478143 wds:Q37004023-9FA5A8AE-9BB5-41AD-A839-9D1D8D649D96 wds:Q37004023-A62F40E3-3D66-4A2E-9A45-E126031ACBC3 wds:Q37004023-A91F8E4C-C42F-4DDF-83C4-F1ADAD8B182E wds:Q37004023-AC12D15D-0C7F-41F0-A865-ED22D6F81567 wds:Q37004023-AE03F177-28B8-40E3-8271-867A63782EC6 wds:Q37004023-B458F63B-439C-41FA-9724-629435E0134B wds:Q37004023-B50F4A88-9E80-473C-B659-B2B877278161 wds:Q37004023-BCEC84C4-6350-47B8-A3CA-2EB0500C6182 wds:Q37004023-C7DF77FB-88DC-4818-AF1E-6FF76D9D92EF wds:Q37004023-D3668C9D-2DF9-4ACF-AC89-7883E98934F5 wds:Q37004023-D9DB5CCF-14DD-46D4-9A4B-6EDF1EEE066D wds:Q37004023-E4B6672C-FB1E-46FF-B660-E08417248F89 wds:Q37004023-E82390FC-C564-4814-B3E8-4D8B1E7415FA wds:Q37004023-E985B61A-65C7-4ED5-9544-D3117D2725CB wds:Q37004023-F5E6F0FC-6278-4D5A-9F67-141E65F785CA
cites work	Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group Optimal medical therapy with or without PCI for stable coronary disease Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Pat Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE). Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials Current strategies for the prevention of angina in patients with stable coronary artery disease Economic evaluation of the impact of nicorandil in angina (IONA) trial. Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study Ranolazine is associated with cardiovascular and metabolic improvement: a win-win for patients with diabetes Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris Effects of lifestyle modification on the progression of coronary atherosclerosis, autonomic function, and angina--the role of GNB3 C825T polymorphism. Antianginal efficacy of omapatrilat in patients with chronic angina pectoris Ranolazine and other antianginal therapies in the era of the drug-eluting stent
author name string	wds:Q37004023-4342D777-ACAD-42E4-BC25-0112BA40366A wds:Q37004023-849631AA-5EFB-49CB-B816-2DE01D3B4F7D
author name string	Rohit R Arora Pawan D Patel
rdfs:label	Utility of ranolazine in chronic stable angina patients. (en) Utility of ranolazine in chronic stable angina patients. (nl) Utility of ranolazine in chronic stable angina patients. (ast)
skos:prefLabel	Utility of ranolazine in chronic stable angina patients. (en) Utility of ranolazine in chronic stable angina patients. (nl) Utility of ranolazine in chronic stable angina patients. (ast)
name	Utility of ranolazine in chronic stable angina patients. (en) Utility of ranolazine in chronic stable angina patients. (nl) Utility of ranolazine in chronic stable angina patients. (ast)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 173 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software